# NDUFA4L2

## Overview
NDUFA4L2 is a gene that encodes the protein NDUFA4 mitochondrial complex associated like 2, which is a component of the mitochondrial electron transport chain, specifically associated with Complex I. This protein is involved in the regulation of oxidative phosphorylation, particularly under hypoxic conditions, by modulating mitochondrial activity and reducing oxygen consumption. This function is crucial for maintaining redox homeostasis and preventing excessive production of reactive oxygen species (ROS), thereby promoting cell survival and proliferation. NDUFA4L2 is regulated by hypoxia-inducible factor 1-alpha (HIF-1α), which induces its expression in response to low oxygen levels, allowing cells to adapt their metabolic processes to hypoxic environments. The protein's role in cellular metabolism and its involvement in conditions such as hypoxic pulmonary arterial hypertension and clear cell renal cell carcinoma highlight its significance in both physiological and pathological contexts (Lai2016NDUFA4L2; Xu2019Mitochondrial; Liu2020NDUFA4L2).

## Function
NDUFA4L2 is a gene encoding a protein that is part of the mitochondrial electron transport chain, specifically associated with complex I. This protein plays a crucial role in modulating oxidative phosphorylation, particularly under hypoxic conditions, by reducing mitochondrial activity and oxygen consumption. This modulation helps prevent excessive production of reactive oxygen species (ROS), thereby maintaining redox homeostasis and promoting cell survival and proliferation (Lai2016NDUFA4L2; Xu2019Mitochondrial).

NDUFA4L2 is regulated by hypoxia-inducible factor 1-alpha (HIF-1α), which induces its expression in response to low oxygen levels. This regulation is essential for cellular adaptation to hypoxia, as it allows cells to fine-tune their metabolic processes to ensure survival in low-oxygen environments (Lai2016NDUFA4L2; Liu2020NDUFA4L2). The protein is active in the mitochondria, where it influences energy production and cellular metabolism by controlling oxidative phosphorylation and ROS production (Xu2019Mitochondrial).

In healthy human cells, NDUFA4L2's function in regulating mitochondrial activity and oxidative stress is vital for maintaining cellular homeostasis, particularly in tissues that frequently experience hypoxic conditions, such as those involved in vascular remodeling and tumor progression (Lai2016NDUFA4L2; Liu2020NDUFA4L2).

## Clinical Significance
NDUFA4L2 is significantly implicated in clear cell renal cell carcinoma (ccRCC), where its overexpression is associated with poor prognosis and aggressive tumor characteristics. High levels of NDUFA4L2 correlate with shorter overall survival, increased recurrence, and advanced tumor features such as depth of invasion and metastasis (Liu2016NDUFA4L2). The gene is a target of hypoxia-inducible factor 1 (HIF-1) and is upregulated in response to hypoxic conditions, which are prevalent in the tumor microenvironment (Liu2016NDUFA4L2; Lucarelli2018Integrated).

NDUFA4L2 contributes to the metabolic reprogramming of cancer cells by promoting a shift from oxidative phosphorylation to glycolysis, a hallmark of cancer metabolism known as the Warburg effect. This shift is associated with mitochondrial dysfunction and chemoresistance in ccRCC (Laursen2021Mitochondrial; Lucarelli2018Integrated). Silencing NDUFA4L2 in cancer cells has been shown to increase mitochondrial membrane potential and reactive oxygen species production, indicating its role in maintaining mitochondrial function and contributing to chemoresistance (Lucarelli2018Integrated).

The gene's overexpression is also linked to increased angiogenesis and lipid accumulation, further contributing to ccRCC progression (Laursen2021Mitochondrial; Lucarelli2018Integrated). These findings suggest that NDUFA4L2 could serve as a potential therapeutic target in ccRCC (Lucarelli2018Integrated).

## Interactions
NDUFA4L2 is a protein associated with the mitochondrial electron transport chain, specifically interacting with components of Complex I. It plays a role in regulating mitochondrial oxidative phosphorylation and reactive oxygen species (ROS) production. In the context of hypoxic pulmonary arterial hypertension (PAH), NDUFA4L2 interacts with the hypoxia-inducible factor 1-alpha (HIF1α) pathway. This interaction is crucial as NDUFA4L2 expression is abolished when HIF1α is knocked down, indicating a regulatory relationship between these proteins in response to hypoxic conditions (Liu2020NDUFA4L2).

NDUFA4L2 also influences the downstream p38-5-lipoxygenase (5-LO) signaling pathway, which is involved in the proliferation of pulmonary artery smooth muscle cells (PASMCs) and contributes to vascular remodeling in PAH (Liu2020NDUFA4L2). In clear cell renal cell carcinoma (ccRCC), NDUFA4L2 is implicated in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction. It is a target gene of HIF-1 and is involved in reducing mitochondrial oxygen consumption by inhibiting Complex I activity, which affects cellular bioenergetics and ROS management (Lucarelli2018Integrated). These interactions highlight NDUFA4L2's role in cellular responses to hypoxia and its potential as a therapeutic target in diseases characterized by altered mitochondrial function.


## References


[1. (Xu2019Mitochondrial) Wen-Ning Xu, Huo-Liang Zheng, Run-Ze Yang, Tao Liu, Wei Yu, Xin-Feng Zheng, Bo Li, Sheng-Dan Jiang, and Lei-Sheng Jiang. Mitochondrial ndufa4l2 attenuates the apoptosis of nucleus pulposus cells induced by oxidative stress via the inhibition of mitophagy. Experimental &amp; Molecular Medicine, 51(11):1–16, November 2019. URL: http://dx.doi.org/10.1038/s12276-019-0331-2, doi:10.1038/s12276-019-0331-2. This article has 39 citations.](https://doi.org/10.1038/s12276-019-0331-2)

[2. (Liu2020NDUFA4L2) Yun Liu, Xiaowei Nie, Jinquan Zhu, Tianyan Wang, Yanli Li, Qian Wang, and Zengxian Sun. Ndufa4l2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension. Journal of Cellular and Molecular Medicine, 25(2):1221–1237, December 2020. URL: http://dx.doi.org/10.1111/jcmm.16193, doi:10.1111/jcmm.16193. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.16193)

[3. (Liu2016NDUFA4L2) Lei Liu, Gongbin Lan, Longkai Peng, Xubiao Xie, Fenghua Peng, Shaojie Yu, Yu Wang, and Xiaotian Tang. Ndufa4l2 expression predicts poor prognosis in clear cell renal cell carcinoma patients. Renal Failure, 38(8):1199–1205, July 2016. URL: http://dx.doi.org/10.1080/0886022X.2016.1208517, doi:10.1080/0886022x.2016.1208517. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/0886022X.2016.1208517)

[4. (Laursen2021Mitochondrial) Kristian B. Laursen, Qiuying Chen, Francesca Khani, Nabeel Attarwala, Steve S. Gross, Lukas Dow, David M. Nanus, and Lorraine J. Gudas. Mitochondrial ndufa4l2 enhances deposition of lipids and expression of ca9 in the track model of early clear cell renal cell carcinoma. Frontiers in Oncology, December 2021. URL: http://dx.doi.org/10.3389/fonc.2021.783856, doi:10.3389/fonc.2021.783856. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.783856)

[5. (Lai2016NDUFA4L2) Robin Kit-Ho Lai, Iris Ming-Jing Xu, David Kung-Chun Chiu, Aki Pui-Wah Tse, Larry Lai Wei, Cheuk-Ting Law, Derek Lee, Chun-Ming Wong, Maria Pik Wong, Irene Oi-Lin Ng, and Carmen Chak-Lui Wong. Ndufa4l2 fine-tunes oxidative stress in hepatocellular carcinoma. Clinical Cancer Research, 22(12):3105–3117, June 2016. URL: http://dx.doi.org/10.1158/1078-0432.CCR-15-1987, doi:10.1158/1078-0432.ccr-15-1987. This article has 79 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.CCR-15-1987)

[6. (Lucarelli2018Integrated) Giuseppe Lucarelli, Monica Rutigliano, Fabio Sallustio, Domenico Ribatti, Andrea Giglio, Martina Lepore Signorile, Valentina Grossi, Paola Sanese, Anna Napoli, Eugenio Maiorano, Cristina Bianchi, Roberto A. Perego, Matteo Ferro, Elena Ranieri, Grazia Serino, Lauren N. Bell, Pasquale Ditonno, Cristiano Simone, and Michele Battaglia. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of ndufa4l2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma. Aging, 10(12):3957–3985, December 2018. URL: http://dx.doi.org/10.18632/aging.101685, doi:10.18632/aging.101685. This article has 137 citations and is from a peer-reviewed journal.](https://doi.org/10.18632/aging.101685)